The regulation of MDM2 oncogene and its impact on human cancers

被引:136
作者
Zhao, Yuhan [1 ]
Yu, Haiyang [1 ]
Hu, Wenwei [1 ,2 ]
机构
[1] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, Dept Pharmacol, New Brunswick, NJ 08903 USA
基金
美国国家卫生研究院;
关键词
MDM2; E3 ubiquitin ligase; gene regulation; p53; TUMOR-SUPPRESSOR PATHWAY; P53-MDM2 FEEDBACK LOOP; UBIQUITIN LIGASE ACTIVITY; RIBOSOMAL-PROTEIN L26; LI-FRAUMENI-SYNDROME; DNA-DAMAGE; ACTIVATES P53; MUTANT P53; P53-DEPENDENT MANNER; ONCOPROTEIN MDM2;
D O I
10.1093/abbs/gmt147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 plays a central role in preventing tumor formation. The levels and activity of p53 is under tight regulation to ensure its proper function. Murine double minute 2 (MDM2), a p53 target gene, is an E3 ubiquitin ligase. MDM2 is a key negative regulator of p53 protein, and forms an auto-regulatory feedback loop with p53. MDM2 is an oncogene with both p53-dependent and p53-independent oncogenic activities, and often has increased expression levels in a variety of human cancers. MDM2 is highly regulated; the levels and function of MDM2 are regulated at the transcriptional, translational and post-translational levels. This review provides an overview of the regulation of MDM2. Dysregulation of MDM2 impacts significantly upon the p53 functions, and in turn the tumorigenesis. Considering the key role that MDM2 plays in human cancers, a better understanding of the regulation of MDM2 will help us to develop novel and more effective cancer therapeutic strategies to target MDM2 and activate p53 in cells.
引用
收藏
页码:180 / 189
页数:10
相关论文
共 119 条
[1]   Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation [J].
Amato, Rosario ;
D'Antona, Lucia ;
Porciatti, Giovanni ;
Agosti, Valter ;
Menniti, Miranda ;
Rinaldo, Cinzia ;
Costa, Nicola ;
Bellacchio, Emanuele ;
Mattarocci, Stefano ;
Fuiano, Giorgio ;
Soddu, Silvia ;
Paggi, Marco G. ;
Lang, Florian ;
Perrotti, Nicola .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2009, 87 (12) :1221-1239
[2]   MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination [J].
Badciong, JC ;
Haas, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49668-49675
[3]   Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study [J].
Bar-Or, RL ;
Maya, R ;
Segel, LA ;
Alon, U ;
Levine, AJ ;
Oren, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11250-11255
[4]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[5]   Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines [J].
Bartel, F ;
Taylor, AC ;
Taubert, H ;
Harris, LC .
ONCOLOGY RESEARCH, 2001, 12 (11-12) :451-457
[6]   Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide [J].
Bernal, Federico ;
Tyler, Andrew F. ;
Korsmeyer, Stanley J. ;
Walensky, Loren D. ;
Verdine, Gregory L. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (09) :2456-+
[7]  
Biderman Lynn, 2012, Genes Cancer, V3, P264, DOI 10.1177/1947601912455331
[8]   MdmX Is Required for p53 Interaction with and Full Induction of the Mdm2 Promoter after Cellular Stress [J].
Biderman, Lynn ;
Poyurovsky, Masha V. ;
Assia, Yael ;
Manley, James L. ;
Prives, Carol .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (07) :1214-1225
[9]   Mutant p53 protein, master regulator of human malignancies: a report on the fifth Mutant p53 Workshop [J].
Blandino, G. ;
Deppert, W. ;
Hainaut, P. ;
Levine, A. ;
Lozano, G. ;
Olivier, M. ;
Rotter, V. ;
Wiman, K. ;
Oren, M. .
CELL DEATH AND DIFFERENTIATION, 2012, 19 (01) :180-183
[10]   THE P53-ASSOCIATED PROTEIN MDM2 CONTAINS A NEWLY CHARACTERIZED ZINC-BINDING DOMAIN CALLED THE RING FINGER [J].
BODDY, MN ;
FREEMONT, PS ;
BORDEN, KLB .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (05) :198-199